BlueRock Therapeutics has reported a new achievement in regenerative medicine – its employees have managed to implant modified neurons into the human brain to stimulate dopamine production. A year ago, this procedure was carried out for 12 patients with pronounced symptoms of Parkinson’s disease. The success lies in the fact that during this time the foreign fragments were not rejected by the organisms of the subjects.
Ideally, scientists would like to be able to simply replace cells that have degenerated with lab-created analogues with new functions. This would increase the production of dopamine, which would help to stop or cure Parkinson’s disease. And indeed, the subjects were less likely to experience attacks of helplessness and incapacity than they were before participating in the experiment.
